Milhem, M., Zakharia, Y., Davar, D., Buchbinder, E., Medina, T., Daud, A., Ribas, A., Niu, J., Gibney, G., Margolin, K., Olszanski, A., Mehmi, I., Sato, T., Shaheen, M., Morris, A., Mauro, D., Campbell, K., Bao, R., Weiner, G., Luke, J., Krieg, A., & Kirkwood, J. (n.d.). o85 Durable responses in anti-PD-1 refractory melanoma following intratumoral injection of a toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab. Journal for immunotherapy of cancer, 8, A2–A3. http://access.bl.uk/ark:/81055/vdc_100137785043.0x000001